Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Biovaxys Technology Corp (BIOV.CN)

Biovaxys Technology Corp (BIOV.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 34,531
  • Shares Outstanding, K 90,870
  • Annual Sales, $ 0 K
  • Annual Income, $ -1,174 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.68
Trade BIOV.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.08
  • Most Recent Earnings -0.01 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.315 +22.22%
on 10/06/21
0.480 -19.79%
on 09/29/21
-0.080 (-17.20%)
since 09/27/21
3-Month
0.200 +92.50%
on 08/26/21
0.650 -40.77%
on 09/20/21
+0.170 (+79.07%)
since 07/27/21
52-Week
0.140 +175.00%
on 01/08/21
0.780 -50.64%
on 02/16/21
-0.075 (-16.30%)
since 10/27/20

Most Recent Stories

More News
Faster, Cheaper, More Reliable COVID-19 Tests Needed for the Unprecedented Demand Ahead

/PRNewswire/ -- USA News Group - It may have its beginning for the UK travel industry, but there are signs of the end of using polymerase chain reaction,...

BVAXF : 0.3000 (unch)
ABT : 127.71 (-0.33%)
BDX : 245.00 (-0.55%)
QDEL : 132.29 (-1.20%)
CVS : 88.09 (-0.26%)
BIOV.CN : 0.375 (-1.32%)
Are We Coming to the End of Using the PCR Covid-19 Test?

VANCOUVER – Biotech Today – It may have its beginning for the UK travel industry, but there ...

BVAXF : 0.3000 (unch)
BDX : 245.00 (-0.55%)
QDEL : 132.29 (-1.20%)
CVS : 88.09 (-0.26%)
ABT : 127.71 (-0.33%)
BDX.CN : 0.750 (unch)
BIOV.CN : 0.375 (-1.32%)
Stocks in play: BioVaxys Technology Corp.

Announced today that it has filed with the United States Patent & Trademark Office a provisional patent ...

BIOV.CN : 0.375 (-1.32%)
Scientific Reports Revealing Early Promise for Universal Coronavirus Vaccine

/PRNewswire/ -- FinancialNewsMedia.com News Commentary - Recently, scientific reports have shown that a universal coronavirus vaccine that protects against...

BVAXF : 0.3000 (unch)
MRNA : 340.88 (-1.41%)
SRNE : 6.69 (-0.59%)
DVAX : 19.70 (+2.71%)
INO : 6.79 (-0.73%)
BIOV.CN : 0.375 (-1.32%)
Alternative Covid-19 Vaccines on the Way, as Biotech Developers Seek to Improve Upon the Jab

VANCOUVER – Biotech Today – As vaccine passport programs continue to roll out in new markets ...

BVAXF : 0.3000 (unch)
NVAX : 141.55 (+4.86%)
SNY : 49.57 (-0.78%)
GSK : 40.42 (+0.60%)
INO : 6.79 (-0.73%)
BIOV.CN : 0.375 (-1.32%)
False Positives Scare Highlights Need for Changes to Covid-19 Testing Processes

VANCOUVER – USA News Group – A round of false positive test results caused a stir on the ...

BVAXF : 0.3000 (unch)
BDX : 245.00 (-0.55%)
QGEN : 53.44 (-2.73%)
ABT : 127.71 (-0.33%)
DGX : 143.94 (-1.07%)
BIOV.CN : 0.375 (-1.32%)
Stocks in play: BioVaxys Technology Corp.

Announced today that it has initiated what could be a scientifically groundbreaking study on the reduced ...

BIOV.CN : 0.375 (-1.32%)
Why New Covid-19 Test Supplies Will Be Needed Soon in Wake of US President’s New OSHA Mandates

VANCOUVER – USA News Group – More than 80 million workers in the United States are now facing ...

QGEN : 53.44 (-2.73%)
ABT : 127.71 (-0.33%)
QDEL : 132.29 (-1.20%)
DGX : 143.94 (-1.07%)
BIOV.CN : 0.375 (-1.32%)
Scientists Rapidly Advancing Cancer Vaccine Prospects Using Same Technology as Covid-19 Shots

VANCOUVER – USA News Group – Using the same technology as their Covid-19 shot, scientists ...

BVAXF : 0.3000 (unch)
AZN : 61.77 (-0.79%)
BNTX : 278.77 (-4.66%)
MRNA : 340.88 (-1.41%)
CVAC : 38.38 (-1.36%)
BIOV.CN : 0.375 (-1.32%)
Stocks in play: BioVaxys Technology Corp.

Announced today that cancer vaccine manufacturing partner Bio Elpida in Lyon, France , has reached major ...

BIOV.CN : 0.375 (-1.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 0.403
2nd Resistance Point 0.397
1st Resistance Point 0.388
Last Price 0.375
1st Support Level 0.373
2nd Support Level 0.367
3rd Support Level 0.358

See More

52-Week High 0.780
Fibonacci 61.8% 0.536
Fibonacci 50% 0.460
Fibonacci 38.2% 0.384
Last Price 0.375
52-Week Low 0.140

See More

Business Summary

BioVaxys Technology Corp is a clinical-stage biopharma company. The company develops antiviral and anticancer vaccine platforms to treat SARS-CoV-2 and other viral infections, as well as ovarian cancer and other solid tumor types.

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar